Search | IOVS | ARVO Journals

Showing 1 – 20 of 59

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Pooled safety analysis of the CANDELA, PHOTON, and PULSAR trials up to 96 weeks demonstrates comparable safety profiles with aflibercept 8 mg and 2 mg

Andreas Stahl; Eric Schneider; Ursula Maria Schmidt-Ott; Claudia Tueckmantel; Andrea Schulze; Alyson J Berliner; Karen W Chu; Robert Vitti; Kimberly Reed; xin Zhang; Peter Morgan-Warren; Rohini Rao; Sergio Leal

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):217.

ARVO Annual Meeting Abstract June 2024

Trends in ROP screening and treatment in Germany over 13 years: Effects of national guideline changes

Tim U. Krohne; Jeany Q. Li; Alexandra T. Camp; Johanna M Pfeil; Wolf A. Lagrèze; Andreas Stahl

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1714.

ARVO Annual Meeting Abstract June 2024

SOCS3 regulates retinal angiogenesis through modulating microglia SPP1 expression

Tianxi Wang; Emil Kriukov; Enton Lam; Andreas Stahl; Mei Chen; guoshuai cai; Petr Y Baranov; Heping Xu; Ye Sun

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1670.

ARVO Annual Meeting Abstract June 2023

Prevalence of ROP severities in a multinational cohort of infants treated for ROP – data from the European ROP registry (EU-ROP)

Johanna M Pfeil; Caner Kara; Aslihan Uzun; Alexander Oscar; Sengül Ozdek; Sabine Aisenbrey; Helge Breuss; Teresa Barth; Karsten Hufendiek; Barbara Glitz; Vinodh Kakkassery; Rainer Guthoff; Karolina Motloch; Sergey Katsan; Georges Caputo; Andreas Stahl

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4913.

ARVO Annual Meeting Abstract June 2023

Ranibizumab for treatment of type 1 ROP: 5 year outcomes of the RAINBOW Trial

Domenico Lepore; Brian W Fleck; Neil Marlow; Alistair Fielder; Andreas Stahl; Han Hao; Annemarie Weisberger; James D Reynolds

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5125.

ARVO Annual Meeting Abstract June 2023

Validation of a Photographic Retinopathy of Prematurity Severity Score (ROP–SS) and Comparison to the Modified Activity Score (mROP–ActS) in a Retrospective SUNDROP Cohort

Christine Liu Xu; Joel Adu-Brimpong; Henry P. Moshfeghi; Tatiana R. Rosenblatt; Michael Yu; Sean Wang; Moosa Zaidi; Hashem Ghoraba; Suzanne Michalak; Natalia F. Callaway; Edward H. Wood; Andreas Stahl; Domenico Lepore; Darius M Moshfeghi

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3346.

ARVO Annual Meeting Abstract June 2023

Expression profiles of potentially angio-modulative microRNAs in the mouse model of oxygen-induced retinopathy (OIR)

Martin Busch; Anna Wenzel; Johanna M Pfeil; Andreas Stahl

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1234.

ARVO Annual Meeting Abstract June 2022

Intravitreal aflibercept compared with laser photocoagulation for infants with retinopathy of prematurity: A FIREFLEYE subgroup analysis

Andreas Stahl; Emine Sukgen; Wei-Chi Wu; Domenico Lepore; Noriyuki Azuma; Hidehiko Nakanishi; Jan Mazela; Thomas Schmelter; Sergio Leal; Evra Koefuencue

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3126.

ARVO Annual Meeting Abstract June 2022

Re-treatments after laser coagulation or anti-VEGF injections in infants treated for retinopathy of prematurity – data from the German ROP registry

Johanna Madeleine Pfeil; Teresa Barth; Wolf Lagrèze; Birgit Lorenz; Karsten Hufendiek; Raffael Liegl; Helge Breuss; Sebastian Bemme; Jakob Ferdinand Meyer; Barbara Glitz; Daniela Suesskind; Ameli Gabel-Pfisterer; Christos Skevas; Tim U Krohne; Vinodh Kakkassery; Andreas Stahl

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4198 – F0258.

Retina May 2022

Single-Cell Protein and Transcriptional Characterization of Epiretinal Membranes From Patients With Proliferative Vitreoretinopathy

PDF

Yannik Laich; Julian Wolf; Rozina Ida Hajdu; Anja Schlecht; Felicitas Bucher; Laurenz Pauleikhoff; Martin Busch; Gottfried Martin; Henrik Faatz; Saskia Killmer; Bertram Bengsch; Andreas Stahl; Albrecht Lommatzsch; Günther Schlunck; Hansjürgen Agostini; Stefaniya Boneva; Clemens Lange
TAGS: epiretinal membrane, proteins, tissue membrane, transcription, genetic, vitreoretinopathy, proliferative, sequence analysis, rna, diagnostic imaging, body tissue
Invest. Ophthalmol. Vis. Sci.. 2022; 63(5):17. https://doi.org/10.1167/iovs.63.5.17

Includes: Supplemental Content

Retina April 2021

Retinal Vessel Functionality Is Linked With ARMS2 A69S and CFH Y402H Polymorphisms and Choroidal Status in AMD Patients

PDF

Elżbieta Krytkowska; Zofia Ulańczyk; Aleksandra Grabowicz; Katarzyna Mozolewska-Piotrowska; Krzysztof Safranow; Andrzej Pałucha; Mariusz Krawczyk; Piotr Sikora; Ewa Matczyńska; Andreas Stahl; Bogusław Machaliński; Anna Machalińska
TAGS: cfh y402h, polymorphism, retinal vessels
Invest. Ophthalmol. Vis. Sci.. 2021; 62(4):30. https://doi.org/10.1167/iovs.62.4.30

Retinal Cell Biology August 2020

CNTF Prevents Development of Outer Retinal Neovascularization Through Upregulation of CxCl10

PDF

Felicitas Bucher; Edith Aguilar; Kyle V. Marra; Julian Rapp; Jakob Arnold; Sophia Diaz-Aguilar; Clemens Lange; Hansjürgen Agostini; Günther Schlunck; Andreas Stahl; Martin Friedlander
TAGS: ciliary neurotrophic factor, retinal neovascularization, up-regulation (physiology)
Invest. Ophthalmol. Vis. Sci.. 2020; 61(10):20. https://doi.org/10.1167/iovs.61.10.20

Includes: Supplemental Content

Articles July 2020

Ranibizumab Population Pharmacokinetics and Free VEGF Pharmacodynamics in Preterm Infants With Retinopathy of Prematurity in the RAINBOW Trial

PDF

Matthew Fidler; Brian W. Fleck; Andreas Stahl; Neil Marlow; James E. Chastain; Jun Li; Domenico Lepore; James D. Reynolds; Michael F. Chiang; Alistair R. Fielder; on behalf of the RAINBOW study group
TAGS: infant, ranibizumab, vascular endothelial growth factor a, infant, premature, retinopathy of prematurity, pharmacodynamics
Trans. Vis. Sci. Tech.. 2020; 9(8):43. https://doi.org/10.1167/tvst.9.8.43

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2020

Incidence of retinopathy of prematurity in a higher gestational age cohort in Germany: Evaluation of current screening criteria

Tim U Krohne; Andreas Müller; Andreas Stahl; Wolf A Lagrèze; Frank G Holz; Petra P. Larsen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2160.

ARVO Annual Meeting Abstract June 2020

Transcriptional Profiling of Human Hyalocytes

Stefaniya Boneva; Julian Wolf; Anja Schlecht; Gabriele Prinz; Peter Wieghofer; Ingo Hilgendorf; Andreas Stahl; Milena Stech; Thomas Ness; Thomas Reinhard; Günther Schlunck; Hansjürgen Agostini; Clemens Lange

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5003.

ARVO Annual Meeting Abstract July 2019

Temporo-spatial distribution and transcriptional profile of retinal microglia cells in the oxygen-induced retinopathy mouse model

Myriam Milena Sophie Böck; Nora Hagemeyer; Peter Wieghofer; Anja Schlecht; Dilmurat Yusuf; Peipei Zhang; Stefaniya Konstantinova Boneva; Adrian Thien; Yannik Laich; Andreas Stahl; Gunther R Schlunck; Hansjürgen Agostini; Marco Prinz; Clemens Lange

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3991.

ARVO Annual Meeting Abstract July 2019

Retreatment needs of patients with proliferative diabetic retinopathy treated with ranibizumab, laser or combination therapy

Andreas Stahl; Sandra Liakopoulos; Katrin Lorenz; Claudia Quiering; Laureen Sander; Georg Spital; Gabriele E Lang

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1734.

ARVO Annual Meeting Abstract July 2019

Influence of ranibizumab, laser photocoagulation or combination therapy on high-risk proliferative diabetic retinopathy

Katrin Lorenz; Gabriele E Lang; Andreas Stahl; Claudia Quiering; Laureen Sander; Georg Spital; Sandra Liakopoulos

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2789.

Cornea October 2018

Semaphorin 3F Modulates Corneal Lymphangiogenesis and Promotes Corneal Graft Survival

PDF

Tristan Reuer; Ann-Charlott Schneider; Bertan Cakir; Anima D. Bühler; Johanna M. Walz; Thabo Lapp; Clemens Lange; Hansjürgen Agostini; Günther Schlunck; Claus Cursiefen; Thomas Reinhard; Felix Bock; Andreas Stahl

Invest. Ophthalmol. Vis. Sci.. 2018; 59(12):5277-5284. https://doi.org/10.1167/iovs.18-24287

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2018

CxCl10 mediates CNTF inhibition of outer retinal neovascularization

Felicitas Bucher; Edith Aguilar; Kyle V Marra; Andreas Stahl; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5327.

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Pooled safety analysis of the CANDELA, PHOTON, and PULSAR trials up to 96 weeks demonstrates comparable safety profiles with aflibercept 8 mg and 2 mg

Trends in ROP screening and treatment in Germany over 13 years: Effects of national guideline changes

SOCS3 regulates retinal angiogenesis through modulating microglia SPP1 expression

Prevalence of ROP severities in a multinational cohort of infants treated for ROP – data from the European ROP registry (EU-ROP)

Ranibizumab for treatment of type 1 ROP: 5 year outcomes of the RAINBOW Trial

Validation of a Photographic Retinopathy of Prematurity Severity Score (ROP–SS) and Comparison to the Modified Activity Score (mROP–ActS) in a Retrospective SUNDROP Cohort

Expression profiles of potentially angio-modulative microRNAs in the mouse model of oxygen-induced retinopathy (OIR)

Intravitreal aflibercept compared with laser photocoagulation for infants with retinopathy of prematurity: A FIREFLEYE subgroup analysis

Re-treatments after laser coagulation or anti-VEGF injections in infants treated for retinopathy of prematurity – data from the German ROP registry

Single-Cell Protein and Transcriptional Characterization of Epiretinal Membranes From Patients With Proliferative Vitreoretinopathy

Retinal Vessel Functionality Is Linked With ARMS2 A69S and CFH Y402H Polymorphisms and Choroidal Status in AMD Patients

CNTF Prevents Development of Outer Retinal Neovascularization Through Upregulation of CxCl10

Ranibizumab Population Pharmacokinetics and Free VEGF Pharmacodynamics in Preterm Infants With Retinopathy of Prematurity in the RAINBOW Trial

Incidence of retinopathy of prematurity in a higher gestational age cohort in Germany: Evaluation of current screening criteria

Transcriptional Profiling of Human Hyalocytes

Temporo-spatial distribution and transcriptional profile of retinal microglia cells in the oxygen-induced retinopathy mouse model

Retreatment needs of patients with proliferative diabetic retinopathy treated with ranibizumab, laser or combination therapy

Influence of ranibizumab, laser photocoagulation or combination therapy on high-risk proliferative diabetic retinopathy

Semaphorin 3F Modulates Corneal Lymphangiogenesis and Promotes Corneal Graft Survival

CxCl10 mediates CNTF inhibition of outer retinal neovascularization

To View More...

You must be signed into an individual account to use this feature.